Advertisement

Vaskulitiden: Spezielle Krankheitsbilder

  • Beatrice Amann-Vesti
  • Adriano Fontana
  • Peter Kuhlencordt
  • Justus G. Müller
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Abstract

Die Panarteriitis nodosa wurde von Kussmaul und Maier 1866 beschrieben und damals Periarteriitis nodosa genannt aufgrund der vielen kleinen Knötchen, die entlang einer muskulären Arterie zu finden sind. Als man die wahre Natur der Knötchen erkannte, wurde die Krankheit in Pan- oder Polyarteriitis nodosa (PAN) umbenannt. Es handelt sich um eine nekrotisierende Arteriitis, die kleine und mittelgroße Arterien der meisten Organe befallen kann. Typischerweise sind die Nieren und Viszeralarterien betroffen. Bei der klassischen PAN sind die Pulmonalarterien nicht mitbetroffen, Bronchialgefäße können aber beteiligt sein.

Literatur

  1. Al Dhanhani A, Macaulay R, Maloney B, Hanly JG (2006) Meningeal involvement in Wegener’s granulomatois. J Rheumatol 33:364–367PubMedGoogle Scholar
  2. Antoniu SA (2007) Treatment options for refractory Wegener’s granulomatosis: a role for rituximab? Curr Opin Investig Drugs 8(11):927–932PubMedGoogle Scholar
  3. Ashton-Key MR, Gallagher PJ (1992) False-negative temporal artery biopsy. Am J Surg Pathol 16:634–635CrossRefGoogle Scholar
  4. Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246–249CrossRefGoogle Scholar
  5. Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol:1810–1817Google Scholar
  6. Burke AP, Virmani R (2001) Review: localized vasculitis. Semin Diagn Pathol 18:59–66PubMedGoogle Scholar
  7. Cotch MF et al (1996) The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution form population-based data sources. Arthritis Rheum 39:87–92CrossRefGoogle Scholar
  8. Evans JM, O’Fallon WM, Hunder GG (1995) Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 122:502–507CrossRefGoogle Scholar
  9. Feiner HD, Raghavendra BN, Phelps R, Rooney L (1984) Inflammatory abdominal aortic aneurysm. Report of six cases. Hum Pathol 15:454–459CrossRefGoogle Scholar
  10. Gilmour JR (1941) Giant-cell chronic arteriitis. J Pathol 53:263–277CrossRefGoogle Scholar
  11. Glück T, Straub RH, Schölmerich J, Lang B (1997) Infections and vasculitis. Z Rheumatol 56(3):105–113CrossRefGoogle Scholar
  12. Guillevin L, Lhote F (1995) Distinguishing polyarteriitis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 7(1):20–24PubMedGoogle Scholar
  13. Guillevin L et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefGoogle Scholar
  14. Hellmann DB (2004) Low-dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum 50:1026–1027CrossRefGoogle Scholar
  15. Hoffman GS et al (1992) Wegener’s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498CrossRefGoogle Scholar
  16. Hoffman GS et al (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46:1309–1318CrossRefGoogle Scholar
  17. Homme JL, Aubry M-C, Tazelaar HD et al (2006) Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 30:1159–1168CrossRefGoogle Scholar
  18. Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153–2165CrossRefGoogle Scholar
  19. Joseph FG, Lammie GA, Scolding NJ (2007) CNS lupus: a study of 41 patients. Neurology 69:644–654CrossRefGoogle Scholar
  20. Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 134:106–114CrossRefGoogle Scholar
  21. Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, Matsumoto Y, Kawakami K, Kasashima F, Moriya M, Kimura K, Ohtake H, Nakanuma Y (2008) Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 32:197–204CrossRefGoogle Scholar
  22. Klein RG, Hunder GG, Stanson AW, Sheps SG (1975) Large artery involvement in giant cell (temporal) arteriitis. Ann Intern Med 83:806–812CrossRefGoogle Scholar
  23. Korte MR, van Heerde MJ, de Man RA, Betjes MH (2008) Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Neth J Med 66(1):27–30PubMedGoogle Scholar
  24. Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98(2):97–111CrossRefGoogle Scholar
  25. Lee MS, Smith SD, Galor A, Hoffman GS (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54:3306–3309CrossRefGoogle Scholar
  26. Lie JT (1995) Aortic and extracranial large vessel giant cell arteriitis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 24:422–431CrossRefGoogle Scholar
  27. Mahr A, Girard T, Agher R, Guillevin L (2005) Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s Granulomatosis and prospective follow-up. Rheumatology 40:492–498CrossRefGoogle Scholar
  28. Miklossy J, Kunther T, Bogouslavsky J, Regli F, Janzer RC (1990) Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol 80:568–572CrossRefGoogle Scholar
  29. Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry M-C, Tazelaar HD (2006) Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 30:1150–1158CrossRefGoogle Scholar
  30. Nesher G, Nesher R (2008) Giant cell arteritis and polymyalgia rheumatica, Chapter 24. In: Ball GV, Bridges SL Jr (Hrsg) Vasculitis. Oxford University Press, OxfordGoogle Scholar
  31. Olin JW, Shih A (2006) Thromboangiitis obliterans (Buerger’s disease). Curr Opin Rheumatol 18:18–24CrossRefGoogle Scholar
  32. Pipitone N, Salvarani C (2008) Improving therapeutic options for patients with giant cell arteriitis. Curr Opin Rheumatol 20:17–22CrossRefGoogle Scholar
  33. Reinhold-Keller E, Beuge N, Latza U, DeGroot K, Rudert H, Nolle B, Heller M, Gross W (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis. Long-term outcome in 155 patients. Arthritis Rheum 43:1021–1032CrossRefGoogle Scholar
  34. Reinhold-Keller E et al (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99CrossRefGoogle Scholar
  35. Rose AG, Dent DM (2006) Inflammatory variant of abdominal atherosclerotic aneurysm. Arch Pathol Lab Med 105:409–413 (1980)Google Scholar
  36. Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, Iwasaki H, Kojima M (2008) IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 32:553–559CrossRefGoogle Scholar
  37. Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteriitis. N Engl J Med 347(4):261–271CrossRefGoogle Scholar
  38. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442–451. Comment in: Ann Neurol 62:430–432CrossRefGoogle Scholar
  39. Saulsbury FT (2007) Clinical update: Henoch-Schönlein purpura. Lancet 369:976–978CrossRefGoogle Scholar
  40. Schaublin GA, Michet CJ, Dyck PJ, Burns TM (2005) An update on the classification and treatment of vasculitic neuropathy. Lancet Neurol 4:853–865CrossRefGoogle Scholar
  41. Schmidt WA (2006) Takayasu and temporal arteriitis. Front Neurol Neurosci 21:96–104CrossRefGoogle Scholar
  42. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteriitis. Rheumatology (Oxford) 47(1):96–101CrossRefGoogle Scholar
  43. Scott TF, Vandora K, Valeri A, Chieffe C, Schramke C (2007) Aggressive therapy for neurosarcoidosis: long-term follow up of 48 treated patients. Arch Neurol 64:691–696CrossRefGoogle Scholar
  44. Segelmark M, Selga D (2007) The challenge of managing patients with polyarteriitis nodosa. Curr Opin Rheumatol 19(1):33–38CrossRefGoogle Scholar
  45. Simon RW, Fritz T, Amann-Vesti BR, Romer GS, Fischer B, Kagi MK (2005) An unusual presentation of giant cell arteriitis. Vasa 34(2):128–130CrossRefGoogle Scholar
  46. Siva A, Altintas A, Sapi S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17:347–357CrossRefGoogle Scholar
  47. Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68:1079–1080CrossRefGoogle Scholar
  48. Steere AC (2001) Lyme disease. N Engl J Med 345:115–125CrossRefGoogle Scholar
  49. Tato F, Hoffmann U (2006) Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 44:176–182CrossRefGoogle Scholar
  50. Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS (2007) Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore) 86:269–277CrossRefGoogle Scholar
  51. Warrington KJ, Matteson EL (2007) Management guidelines and outcome measures in giant cell arteriitis (GCA). Clin Exp Rheumatol 25(Suppl 47):137–141PubMedGoogle Scholar
  52. Weidner N (2001) Giant-cell vasculitides. Sem. Diagn Pathol 18:24–33Google Scholar
  53. Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteriitis as a cause of first-ever stroke. Cerebrovasc Dis 24:226–230CrossRefGoogle Scholar
  54. Woude FJ van der, Rasmussen N, Lobatto S, et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1:425–429Google Scholar
  55. Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B, Czarnacki M, Doskocz R, Kowal-Gierczak B (2000) Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Angiology 51:141–150CrossRefGoogle Scholar
  56. Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management and advances in treatment. Nat Clin Pract Rheumatol 3:148–155CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  • Beatrice Amann-Vesti
    • 1
  • Adriano Fontana
    • 2
  • Peter Kuhlencordt
    • 3
  • Justus G. Müller
    • 4
  1. 1.Herz-Gefäss Zentrum Klinik im ParkZürichSchweiz
  2. 2.Klinik für Immunologie MOU 19Universitätsspital ZürichZürichSchweiz
  3. 3.konservative und interventionelle AngiologieAsklepios Klinik AltonaHamburgDeutschland
  4. 4.Pathologisches Institut der UniversitätLuitpoldkrankenhausWürzburgDeutschland

Personalised recommendations